Airobes LLC
June 24, 2026
5B
Type: Start-Up Stadium Session
Focus Area:
Platform for Therapeutics
Airobes is a carbon-to-value biotechnology company that developed a two-organism process that utilizes carbon dioxide as the carbon feedstock for bacterial fermentation. Through this process, Airobes unlocks the ability to produce thousands of distinct recombinant proteins. These proteins support numerous biotechnology and healthcare applications, ranging from diagnostics and therapeutics to research reagents. We've achieved full validation of the process, with our first research-use only product, Taq DNA Polymerase, reaching market in Q4 2025. Beyond enabling recombinant protein production using atmospheric CO2 as the carbon feedstock, Airobes process provides secondary revenue streams from carbon capture that can be used to enhance market competitiveness.
Company HQ City:
Phoenix
Company HQ State:
Arizona
Company HQ Country:
United States
Year Founded:
2024
CEO
Jarrett Eshima
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}